In reply to the Letter to the Editor by Cengiz Beyan and Esin Beyan regarding ''Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?"

We have read with great interest the letter to the editor by Cengiz Beyana and Esin Beyan regarding our manuscript on the practicalities of several pretreatment hematological biomarkers including white blood cell (WBC) count, lymphocyte percentage (LY%), haemoglobin, and mean platelet volume (MPV), as prognostic factors for patients with non-metastatic nasopharyngeal carcinoma [ [1] Mao J.R. Lan K.Q. Liu S.L. et al. Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?. Radiother Oncol. 2022; 179: 109445 Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar ]. The prognosis may not be determined with the use of some pre-treatment complete blood count values in patients with non-metastatic nasopharyngeal carcinomaRadiotherapy and OncologyVol. 181PreviewWe read with great interest the retrospective study of Mao et al. suggesting that prognosis can be determined by the use of some pre-treatment complete blood count (CBC) values in patients with non-metastatic nasopharyngeal carcinoma [1]. We would like to emphasize the existence of several factors that may have adversely affected the results of this study. Full-Text PDF